NCT05608382 is a NA clinical trial of sterile Phosphate Buffer Saline in Skin Diseases, Infectious, sponsored by Center for Innovation and Research Organization.

Who is sponsoring NCT05608382?

NCT05608382 is sponsored by Center for Innovation and Research Organization.

What drugs are being tested in NCT05608382?

Interventions in NCT05608382: sterile Phosphate Buffer Saline, SGW13.

What condition does NCT05608382 study?

NCT05608382 studies Skin Diseases, Infectious.

Is NCT05608382 still recruiting?

NCT05608382 is currently completed. Last updated 8 November 2022.

Last reviewed 2022-11-08 · How we verify

NCT05608382

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of an Antiseptic Solution on the Skin Microbiome

Completed NA Last updated 8 November 2022

What this trial tests

NA trial testing sterile Phosphate Buffer Saline in Skin Diseases, Infectious in 50 participants. Completed in 18 March 2022.

Timeline

7 March 2022

Primary endpoint
15 March 2022

18 March 2022

Quick facts

Lead sponsor	Center for Innovation and Research Organization
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	7 March 2022
Primary completion	15 March 2022
Estimated completion	18 March 2022
Sites	1 location across United States

Drugs / interventions tested

sterile Phosphate Buffer Saline
SGW13

Conditions studied

Skin Diseases, Infectious — all drugs for Skin Diseases, Infectious →

Sponsor

Center for Innovation and Research Organization

Who can join

18 and older, any sex, with Skin Diseases, Infectious. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is simulate the clinical use of an antiseptic solution in a 24 hour window and the recovery to baseline conditions at 1 month following application. Efficacy will be simulated as the capacity of the material to reduce or clear the skin bacterial population from a representative skin area: the anteromedial forearm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Center for Innovation and Research Organization trials

Trials by the same sponsor.

NCT05617729 — A Clinical Simulation Study of a Test Material on the Anterior Nares · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05608382 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Center for Innovation and Research Organization
Last refreshed: 8 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05608382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing